The Latest Cardiac and Vascular News
LONDON–(BUSINESS WIRE)–Silence Therapeutics plc (Nasdaq: SLN), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today announced that it will receive a $2.0 million cash payment from Hansoh Pharmaceutical Group Company Limited (“Hansoh”) […]
First use of Philips’ breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter Only FDA-cleared solution for advanced IVC filter removal safely ablates tissue and removes embedded IVC filters in first patients In the USA, estimates show more than […]
MEMPHIS, Tenn. and PEWAUKEE, Wis., April 21, 2022 /PRNewswire/ — Arrowhealth, a technology company specializing in cross-platform Remote Patient Monitoring (RPM) technology, and Lohman Technologies, creators of the hōm ecg+ announced an expansion of their partnership today. In 2021, Arrowhealth partnered with Lohman to bring hōm ecg+ into the portfolio of remote monitoring tools […]
ANDOVER, Mass., April 21, 2022 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on April 18, 2022, TransMedics granted non-qualified stock options to purchase an aggregate of 29,800 shares of its common stock […]
April 20, 2022 New research proposes a four-stage system for measuring the progression of cardiovascular disease (CAD) based on atherosclerotic plaque – not secondary symptoms of heart disease. Quantification of CAD burden and plaque type has demonstrated to be the strongest discriminant of future risk of Major Adverse Cardiac Events […]
VANCOUVER, British Columbia–(BUSINESS WIRE)–Clarius Mobile Health, one of Canada’s leading medical technology companies, has received Health Canada’s approval for its third-generation product line of high-performance handheld ultrasound scanners that wirelessly connect to the clinician’s Apple and Android smart devices with an AI-powered application. Now 30% smaller, lighter, and more affordable, […]
LAGUNA HILLS, Calif. and SHANGHAI and BOCHUM, Germany, April 21, 2022 /PRNewswire/ — Wallaby Medical (“Wallaby” or the “Company”), a global innovative medical technology company focused on developing and commercializing neurovascular interventional products for treating stroke, today announced that it has acquired phenox GmbH, including phenox’s femtos GmbH (“femtos”), (together “phenox”), a German-based global innovation and technology […]
SOUTH JORDAN, Utah, April 21, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, is proud to announce that Brian G. Lloyd, Merit’s Chief Legal Officer and Corporate Secretary, is a recipient of Utah Business Magazine’s Corporate Counsel Award. The award recognizes exceptional […]
Istaroxime significantly improved the systolic blood pressure profile WARRINGTON, Pa., April 20, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced positive primary results with istaroxime in rapidly raising systolic blood pressure, the […]
ALISO VIEJO, Calif., April 20, 2022 /PRNewswire/ — MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a multi-center, prospective EU observational study called STRAIT, to evaluate the Safety and Performance of the BOBBY Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke. The BOBBY Balloon […]
